1. Home
  2. ILMN vs SBS Comparison

ILMN vs SBS Comparison

Compare ILMN & SBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • SBS
  • Stock Information
  • Founded
  • ILMN 1998
  • SBS 1954
  • Country
  • ILMN United States
  • SBS Brazil
  • Employees
  • ILMN N/A
  • SBS N/A
  • Industry
  • ILMN Medical Specialities
  • SBS Water Supply
  • Sector
  • ILMN Health Care
  • SBS Utilities
  • Exchange
  • ILMN Nasdaq
  • SBS Nasdaq
  • Market Cap
  • ILMN 15.9B
  • SBS 13.7B
  • IPO Year
  • ILMN 2000
  • SBS 2002
  • Fundamental
  • Price
  • ILMN $81.09
  • SBS $20.26
  • Analyst Decision
  • ILMN Buy
  • SBS
  • Analyst Count
  • ILMN 18
  • SBS 0
  • Target Price
  • ILMN $127.78
  • SBS N/A
  • AVG Volume (30 Days)
  • ILMN 2.4M
  • SBS 1.2M
  • Earning Date
  • ILMN 05-08-2025
  • SBS 05-12-2025
  • Dividend Yield
  • ILMN 3.83%
  • SBS 3.14%
  • EPS Growth
  • ILMN N/A
  • SBS 184.67
  • EPS
  • ILMN N/A
  • SBS 2.61
  • Revenue
  • ILMN $4,337,000,000.00
  • SBS $6,629,708,013.00
  • Revenue This Year
  • ILMN N/A
  • SBS N/A
  • Revenue Next Year
  • ILMN $3.22
  • SBS $13.13
  • P/E Ratio
  • ILMN N/A
  • SBS $7.86
  • Revenue Growth
  • ILMN N/A
  • SBS 43.80
  • 52 Week Low
  • ILMN $68.70
  • SBS $13.10
  • 52 Week High
  • ILMN $156.66
  • SBS $21.14
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 51.02
  • SBS 50.95
  • Support Level
  • ILMN $78.55
  • SBS $20.55
  • Resistance Level
  • ILMN $85.90
  • SBS $21.13
  • Average True Range (ATR)
  • ILMN 2.77
  • SBS 0.46
  • MACD
  • ILMN 0.19
  • SBS -0.11
  • Stochastic Oscillator
  • ILMN 42.74
  • SBS 44.34

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About SBS Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (Each repstg 250)

Companhia De Saneamento Basico Do Estado De Sao Paulo is engaged in the provision of basic and environmental sanitation services in the Sao Paulo State and supplies treated water and sewage services on a wholesale basis. The company operates in a single segment, which is Sanitation services.

Share on Social Networks: